Dr Randeep Guleria
- India
COVAXIN trial results on children likely by September: AIIMS chief
New Delhi: Trials for Bharat Biotech’s Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria…
- India
All you need to know about white and yellow fungus infections
Ever since COVID-19’s second wave hit India things have taken unpredictable turns leading to several complications in the ones who are actively infected and also the ones who have recovered from the…
- India
Misuse of steroids is cause of mucormycosis, says Randeep Guleria
New Delhi : All India Institute of Medical Sciences’ (AIIMS) Director Randeep Guleria on Saturday said misuse of steroids is a major cause behind mucormycosis. Guleria also urged the hospitals to follow…
- India
Strict lockdown in areas with COVID positivity rate of over 10 pc: Guleria
New Delhi: A strict lockdown should be imposed in areas where the COVID-19 case positivity rate is over 10 per cent or the bed occupancy is above 60 per cent, AIIMS Director…
